Paul Matteis

Paul Matteis joined Stifel in 2018.  Based out of the firm’s Boston office, he serves as a Managing Director and Head of Biotech Research.

Previously, Paul was a Senior Biotechnology Analyst covering small-cap and mid-cap companies at Leerink, with a focus on neuroscience, central nervous system and rare disease. Before this, he was a Research Assistant at the Harvard Division of Sleep Medicine at Brigham & Women’s Hospital.

Paul was named a “Runner Up” in Small/Mid Cap Biotechnology in 2019-2024, as well as a “Rising Star” by Institutional Investor in both 2015 and 2016, as part of the publication’s All-America Research Team rankings.  He attended Skidmore College in New York, where he studied Psychology and Pre-Medical Sciences and graduated Phi Beta Kappa.